Brain activity training with scan feedback for teenagers with Tourette syndrome
Tests scan-guided brain training in teenagers with Tourette syndrome or chronic tics.
Key facts
- Who runs it
- Yale University
- Where
- New Haven, United StatesSee the site
- Trial code
- Registry title
- Neurofeedback From the Supplementary Motor Area for Tourette Syndrome
- Status
- Recruiting
- People taking part
- 64 people, planned
- Started
- 1 Nov 2022
- Expected to end
- 20 Jan 2027
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Neurofeedback from the SMA
- Neurofeedback from control region
- Record updated
- 9 June 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for young people aged 10 to 16 with Tourette Syndrome or chronic tic disorder. They get brain-scan (fMRI) neurofeedback from one of two brain areas.
- Age
- 10 to 16 years
- Sex
- Boys and girls
- Disease stage
- A current diagnosis of Tourette Syndrome or chronic tic disorder. Active tics that can be done without moving the head. A YGTSS tic score of at least 13 for Tourette Syndrome, or at least 12 for chronic tic disorder.
- Earlier treatment
- Medicines must be stable, with no changes planned during the study. Psychotherapy started less than 8 weeks ago is not allowed. Ongoing psychotherapy started at least 8 weeks before can continue.
Main reasons for not taking part
- IQ below 80
- Autism spectrum disorder, bipolar or psychotic disorder, or current suicidal thoughts
- Serious illness such as heart disease, high blood pressure, liver or kidney failure, lung disease or seizures
- Metal medical implants or braces, pregnancy, body weight of 250 lbs (113 kg) or more, or fear of closed spaces
- Living more than 2 hours from Yale Medical Center, or child and parents cannot speak and understand English
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- Boys and girls, 10 to 16 years of age
- A current diagnosis of Tourette Syndrome (TS) or chronic tic disorder (CTD), with active tics that can be executed without head movement, and a YGTSS score of at least 13 (for TS participants) or at least 12 (for CTD participants)
- Currently stable medication treatment and no planned changes in medication for the duration of the study
- Family residence within 2 hours of Yale Medical Center with ability and willingness to attend assessment and fMRI visits
- Children and their parents are expected to be able to speak and understand spoken English in order to participate in a clinical assessment of TS and related psychopathology
- Subjects will be free of: 1) metal medical implants or braces, 2) pregnancy, and will have 3) a body weight of less than 250 lbs. and 4) no claustrophobia
Who cannot take part
- Recently initiated psychotherapy. Participation in the study will not be allowed within 8 weeks of the initiation of psychotherapy. Ongoing, concurrent psychotherapy (that was initiated at least 8 weeks previously) for the child will be allowed, but parents will be asked not to initiate any new psychotherapy for the child during the study
- Current diagnosis of autism spectrum disorder, bipolar or psychotic disorder or current suicidality
- Significant medical condition such as heart disease, hypertension, liver or renal failure, pulmonary disease, seizure disorder
- Subjects may also be excluded after the first MR scan if we are unable to localize the two regions in their brain that are used as targets for the active and control neurofeedback conditions
- Intelligence quotient below 80
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 10 and 16 years old?
Where in United States
- Yale University School Of MedicineNew Haven, United StatesContact: Michelle Hampson, PhD (principal investigator)Taking people
About the trial
What the trial wants to find out
This is a clinical trial where adolescents aged 10-16 years old with Tourette Syndrome (or chronic tic disorder) are randomized to receive either real-time functional magnetic resonance imaging (fMRI) neurofeedback targeting the supplementary motor area (for the experimental intervention) or real-time fMRI neurofeedback (NF) from a control region (for the control intervention).
The 2 groups in the trial
- Neurofeedback from the SMATreatment being tested
- Neurofeedback from control regionExisting treatment, for comparison
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Neurofeedback From the Supplementary Motor Area for Tourette Syndrome
- Plain-language title
- Brain activity training with scan feedback for teenagers with Tourette syndromeGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Fit questions
- Built from NCT05558566, who can take part
- Record updated
- 9 June 2026